Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk
Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Jan 2, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how evaluating and managing other health conditions in patients at high risk for heart problems can help reduce their chances of having serious heart issues in the future. It focuses on patients who are either trying to prevent heart problems before they happen or who have already experienced a major heart event. During their planned hospital stay, these patients will receive personalized care that addresses both their heart health and any other medical issues they may have.
To be eligible for this study, participants must be 18 years or older and have a high risk for heart problems due to factors like high blood pressure, diabetes, or a history of heart events. They will be assessed for their health conditions during their hospital stay. However, individuals who refuse to participate, are not registered in the social security system, or have certain legal or health-related restrictions will not be able to join. Participants can expect to receive comprehensive care tailored to their needs, aimed at improving their overall heart health and reducing risks.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * High-Risk Cardiovascular patients either receiving:
- • Primary prevention because they have never had a cardiovascular event but have several cardiovascular risk factors such as high blood pressure particularly resistant, metabolic syndrome, diabetes , dyslipidemia, metabolic steatosis
- • Or secondary prevention because they have already had a major cardiovascular event such as ischemic heart disease, heart failure
- • Aged 18 and over
- • Patient benefiting from comorbidities assessment during their planned hospitalization in the internal medicine department.
- Exclusion Criteria:
- • Patient refusal
- • Subject not registered in social security system
- • Pregnant or breastfeeding woman
- • Patient unable to give their informed consent, protected adult, vulnerable people
- • Subject deprived of liberty by judicial or administrative decision
About University Hospital, Montpellier
The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, , France
Patients applied
Trial Officials
Camille ROUBILLE, MD
Principal Investigator
University Hospital, Montpellier
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported